Oliver Cope Meritorious Achievement Award
In April of 1984 at the American Association of Endocrine Surgeons meeting in Kansas City, Drs. Edwin Kaplan, Jack Monchik, Leonard Rosoff, Norm Thompson, and Stuart Wilson proposed to the Council a new achievement award. This award is to be given to a member of the AAES in recognition for contributions in the field of endocrine surgery as an investigator, teacher, and clinical surgeon. It is not an annual award but is to be given to members of our Association who have achieved the high standards for which the award was established.
On April 15th, 1985 at the annual meeting of the AAES in Toronto, our President Leonard Rosoff announced the first member to receive this award, Dr. Oliver Cope. In giving this award to Dr. Cope the decision of the Council was that from this day forward the award would be known as the Oliver Cope Meritorious Achievement Award for the American Association of Endocrine Surgeons.
 |
Oliver Cope, MD
Professor of Surgery, Harvard University and the Massachusetts General Hospital
Awarded in Toronto in April 1985 |
 |
Stanley R. Friesen, MD, PhD
Professor of Surgery, University of Kansas
Awarded in Detroit, MI. in April 1994
Dr. Friesen served as the President in 1983 |
 |
Norman W. Thompson, MD
Henry King Ransom Professor of Surgery, University of Michigan
Awarded in Atlanta, GA in April 2001
Dr. Thompson served as the inaugural President in 1980 and 1981 |
 |
Jon A. van Heerden MD
Professor of Surgery Mayo Clinic, Rochester, MN
Awarded in Charlottesville NC in April 2004
Dr. van Heerden served as Recorder from 1987-89, as Vice-President in 1994, and as President in 1996 |
 |
Orlo H. Clark MD
Professor of Surgery, UCSF Mount Zion Medical Center
Awarded in New York, New York in May 2006
Dr. Clark served as the Inaugural Vice President in 1980 and 1981, and as President in 1993 |
 |
Edwin L. Kaplan
Professor of Surgery, University of Chicago
Awarded in Madison, WI in May 2009
Dr. Kaplan served as President in 1982-83 |
 |
George L. Irvin, III MD
University of Miami
Awarded in Pittsburgh, PA in April 2010
Dr. Irvin served as Recorder from 1993-1996, Vice President in 1996-1997 and President in 1998-1999 |
 |
Stuart D. Wilson, MD
Medical College of Wisconsin
Awarded in Baltimore, MD in April 2016
Dr. Wilson served as Secretary-Treasurer from 1984-1988 and President from 1991-1992
|
 |
Quan-Yang Duh, MD
University of California San Francisco
Awarded in Los Angeles, CA in April 2019
Dr. Duh served as Recorder from 1996-1999 and President from 2002-2003 |
 |
Janice Pasieka, MD
University of Calgary
Awarded virtually in April 2021
Dr. Pasieka served as Secretary-Treasurer from 2003-2006 and President from 2009-2010
|
 |
Ashok Shaha, MD
Memorial Sloan Kettering Cancer Center
Awarded in April 2023
Dr. Shaha served as Vice President from 2003-2004 and President from 2011-2012
|
Paul LoGerfo Research Award
The Paul LoGerfo Research Award (PLRA) was developed to honor the life of Paul LoGerfo who made numerous major contributions to the field of endocrine surgery during his esteemed career. Dr LoGerfo passed away from malignant melanoma in 2003 during the peak of his career while serving as President of the American Association of Endocrine Surgeons.
The mission of the PLRA is to enrich the discipline of endocrine surgery and to advance the careers of junior investigators who are interested in a career in academic endocrine surgery. These goals will be pursued by supporting grant proposals that will broaden the horizon of endocrine surgery and advance the career-goals of junior endocrine surgeons. The PLRA welcomes proposals for support of a wide spectrum of research topics including surgical ethics, education, epidemiology, biostatistics, health care delivery, as well as clinical or basic science research pertaining to the field of endocrine surgery. The PLRA may be used for bridge or supplemental funding for research protocols with existing funding.
2024
Lauren Krumeich, MD, MS
Regents of the University of Michigan
"Non-Small Cell Lung Cancer Metastases to the Adrenal Gland: Local Immune Infiltrate and Response to Immunotherapy"
Vivek Sant, MD
UT Southwestern
"Predicting Fracture and Mis-Aligned Care in Primary Hyperparathyroidism"
2023
Claire Graves, MD
University of California Davis
"Dynamic PET/CT for Lateralization of Aldosterone Hypersecretion"
Aditya Shirali, MD
University of Florida
"Characterizing the Role of Immunosenescence in Differentiated Thyroid Cancer in the Older Adult"
2022
James Wu, MD
UCLA David Geffen School of Medicine
"Liquid Biopsy for Thyroid Cancer: Enumeration and Molecular Profiling of Thyroid-derived Extracellular Vesicles"
Taylor C Brown, MD, MHS
Washington University in St. Louis and John Cochran VA
"Credentialing Human DNA Polymerase Theta (POLQ) as a Novel Therapeutic Target in Aggressive Thyroid Cancer"
2021
Priya H. Dedhia, MD, PhD
The Ohio State University
"Targeting Wnt and IGF2 Pathways in adrenocortical carcinoma"
Brenessa Lindeman, MD, MEHP
University of Alabama at Birmingham
"Immunometabolic Glutathione Pathway-dependent Targeting of Tumor Profession in Thyroid Cancer"
2020
Samira Sadowski, MD
National Institutes of Health
"Novel Treatments Targeting Epigenetic Regulation of Somatostatin Receptor Type 2 Expression in Radionuclide-Refractory Neuroendocrine Tumors"
Dawn Elfenbein, MD
University of Wisconsin-Madison
"Randomized Controlled Trial of Preoperative Steroids in Autoimmune Thyroid Disease"
2019
Mahsa Javid, MD, PhD
Medical University of South Carolina
“The role of advanced glycation end products in thyroid cancer”
Naira Baregamian, MD
Vanderbilt University Medical Center
“Immunometabolic Glutathione Pathway-dependent Targeting of Tumor Progression in Thyroid Cancer”
2018
David Schneider, MD
University of Wisconsin
“Using patient language for measuring quality of life in thyroid cancer”
Heather Wachtel, MD
University of Pennsylvania
“Circulating miRNA signatures in primary hyperparathyroidism”
2017
Xavier Keutgen, MD
Rush University Medical Center
Tanscriptional analysis of syndromic and sporadic pancreatic neuroendocrine tumors yields novel genotype specific targets
Raymon Grogan, MD
University of Chicago
Microbiome alterations and thyroid cancer risk
2016
Basic Research
Dhaval Patel, MD
NIH – Endocrine Oncology Branch
Comprehensive Metabolomic Analysis of Adrenocortical Carcinoma: Toward Improved Diagnosis, Prognosis and Therapeutic Targets
Clinical Research
Susan Pitt, MD
University of Wisconsin
Decision-Making about Papillary Thyroid Microcarcinoma Treatment
2015
Basic Research
Brian Untch, MD
Memorial Sloan-Kettering Cancer Center
RTKs in Resistane to RAS Inhibition in Thyroid Cancer
Clinical Research
Insoo Suh, MD
Univeristy of California San Francisco
FDG-PET Imaging for Parathyroid Tumors
2014
Michael Stang
University of Pittsburgh
Lysosome Centered Signaling and Regulation of Autophagy in a Model of Papillary Thyroid Carcinoma
2013
Jason D. Prescott, MD
Johns Hopkins School of Medicine
Development of a High Throughput in vivo Screening System for Small Molecule Activators of Thyroid Differentiation: In Search of Novel Agents for Treatment of Undifferentiated Thyroid Cancer
2012
Daniel Ruan, MD
Brigham and Women’s Hospital
Overcoming Medullary Thyroid Cancer Resistance to Vandetanib: Characterization of the Mechanisms
2011
Naris Nilubol, MD
National Cancer Institute
Identification and Validation of Novel Anticancer Compounds for the Treatment of Adrenocortical Cancer
2010
Rebecca S. Sippel, MD
University of Wisconsin – Madison
Characterization of Age-Related Changes in the Notch1 Pathway in Well-Differentiated Thyroid Cancers
ThyCa: Thyroid Cancer Survivors’ Association Award for Thyroid Cancer Research
The ThyCa: Thyroid Cancer Survivors’ Association Award for Thyroid Cancer Research was developed in 2017 by the generous support of ThyCa to promote and support thyroid cancer research by AAES members. AAES welcomes proposals for support of a wide spectrum of research topics including surgical ethics, education, epidemiology, biostatistics, health care delivery, as well as clinical or basic science research pertaining to the field of thyroid cancer.
2024
Q. Lina Hu, MD
Beth Israel Deaconess Medical Center
"Factors Influencing Guideline-Concordant Care in Thyroid Cancer Management"
2023
Tammy Holm, MD, PhD
University of Cincinnati
"Targeted Autophagy in the Pathogenesis of Anaplastic Thyroid Cancer"
2022
Irene M. Min, PhD
Weill Medical College of Cornell University
"Investigation of CSPG4 Function and Targeting using Metastatic Thyroid Cancer Models Applicant"
2021
Benjamin C. James, MD, MS
Harvard Medical School/Beth Israel Deaconess Medical Center
"Assessing Objective Financial Toxicity in Thyroid Cancer Patients"
2020
Taylor C. Brown, MD, MHS
Washington University
“Mapping of Intratumoral Heterogeneity and Identification of Druggable Targets in Anaplastic Thyroid Cancer using Whole-Exome Sequencing”
2019
Matthew Nehs, MD
Brigham and Women's Hospital
“Metabolic Inhibition of Anaplastic Thyroid Carcinoma”
2018
Lawrence Shirley, MD
Ohio State University Wexner Medical Center
“Integrin linked kinase facilitates communication between cancer associated fibroblasts and immune cells in papillary thyroid cancer”
2017
Melissa Wilson, MD
NYU Langone Medical Center
"Adjuvant targeted therapy to improve efficacy of RAI in early stage BRAF mutant PTC"
